Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.

Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, Lau JY, Sung JJ.

Gut. 2004 Sep;53(9):1244-9.

2.

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS; China Gastric Cancer Study Group.

JAMA. 2004 Jan 14;291(2):187-94.

PMID:
14722144
3.

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.

Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A.

Gut. 2004 Jan;53(1):12-20.

4.

Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.

Liu KS, Wong IO, Leung WK.

World J Gastroenterol. 2016 Jan 21;22(3):1311-20. doi: 10.3748/wjg.v22.i3.1311. Review.

5.

K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer.

Watari J, Tanaka A, Tanabe H, Sato R, Moriichi K, Zaky A, Okamoto K, Maemoto A, Fujiya M, Ashida T, Das KM, Kohgo Y.

J Clin Pathol. 2007 Aug;60(8):921-6. Epub 2006 Sep 22.

6.

Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study.

Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, Leung WK, Ng EK, Lau JY, Lee YT, Yeung CK, Chao W, Chung SC.

Gastroenterology. 2000 Jul;119(1):7-14.

PMID:
10889149
7.

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF Jr, Xu GW, Gail MH.

J Natl Cancer Inst. 2006 Jul 19;98(14):974-83.

PMID:
16849680
8.
9.

Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.

Massarrat S, Haj-Sheykholeslami A, Mohamadkhani A, Zendehdel N, Rakhshani N, Stolte M, Mirzaei M, Saliminejhad M, Saeidi S, Shahidi M.

Arch Iran Med. 2012 Nov;15(11):664-9. doi: 0121511/AIM.004.

10.

Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.

Giuliani A, Spada S, Corona M, Demoro M, Di Bari M, Ricciardulli T, Galati G, Caporale A, Tocchi A, Angelico F.

J Exp Clin Cancer Res. 2003 Sep;22(3):371-8.

PMID:
14582693
11.
12.

Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer.

Kumar D, Dhar A, Dattagupta S, Ahuja V, Mathur M, Sharma MP.

Indian J Gastroenterol. 2002 Jan-Feb;21(1):7-10.

PMID:
11871846
13.

Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).

Miehlke S, Kirsch C, Dragosics B, Gschwantler M, Oberhuber G, Antos D, Dite P, Läuter J, Labenz J, Leodolter A, Malfertheiner P, Neubauer A, Ehninger G, Stolte M, Bayerdörffer E.

World J Gastroenterol. 2001 Apr;7(2):243-7.

14.

The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.

Lee YC, Chen TH, Chiu HM, Shun CT, Chiang H, Liu TY, Wu MS, Lin JT.

Gut. 2013 May;62(5):676-82. doi: 10.1136/gutjnl-2012-302240. Epub 2012 Jun 14.

15.

[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].

Gisbert JP, Boixeda D, Martín de Argila C, Redondo C, Moreno L, Abraira V, García Plaza A.

Med Clin (Barc). 1998 Jan 17;110(1):1-5. Spanish.

PMID:
9527978
16.

Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin.

Kamada T, Haruma K, Komoto K, Mihara M, Chen X, Yoshihara M, Sumii K, Kajiyama G, Tahara K, Kawamura Y.

Helicobacter. 1999 Sep;4(3):204-10.

PMID:
10469195
17.

Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.

Tankovic J, Lamarque D, Lascols C, Soussy CJ, Delchier JC.

Pathol Biol (Paris). 2001 Sep;49(7):528-33.

PMID:
11642014
18.

Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.

Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, Liu WD, Feng GS, Zhang XD, Li J, Lu AP, Xia HH, Lam S, You WC.

Gut. 2012 Jun;61(6):812-8. doi: 10.1136/gutjnl-2011-300154. Epub 2011 Sep 13.

PMID:
21917649
19.

Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.

Watari J, Das KK, Amenta PS, Tanabe H, Tanaka A, Geng X, Lin JJ, Kohgo Y, Das KM.

Clin Gastroenterol Hepatol. 2008 Apr;6(4):409-17. doi: 10.1016/j.cgh.2007.12.044. Epub 2008 Mar 5.

PMID:
18321787

Supplemental Content

Support Center